Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin J Wilson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Host & Microbe|June 19, 2012
Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRIAhmed S Attia, Kaitlin A Schroeder, Erin H Seeley, et al.
Journal of Pediatric Surgery|July 13, 2013
Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapyAndrew J Murphy, Gregory D Ayers, Melissa A Hilmes, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Science Translational Medicine|March 16, 2018
Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactionsJames E Cassat, Jessica L Moore, Kevin J Wilson, et al.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Journal of Medicinal Chemistry|January 13, 2025
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent CancersRishi G Vaswani, David S Huang, Neville Anthony, et al.
Cancer Discovery|April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Justin F Gainor, Rami Rahal, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Host & Microbe|June 19, 2012
Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRIAhmed S Attia, Kaitlin A Schroeder, Erin H Seeley, et al.
Journal of Pediatric Surgery|July 13, 2013
Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapyAndrew J Murphy, Gregory D Ayers, Melissa A Hilmes, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Science Translational Medicine|March 16, 2018
Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactionsJames E Cassat, Jessica L Moore, Kevin J Wilson, et al.
The Journal of Biological Chemistry|January 21, 2011
Structural basis for selective small molecule kinase inhibition of activated c-MetKeith W Rickert, Sangita B Patel, Timothy J Allison, et al.
Journal of Medicinal Chemistry|January 13, 2025
Discovery of FHD-286, a First-in-Class, Orally Bioavailable, Allosteric Dual Inhibitor of the Brahma Homologue (BRM) and Brahma-Related Gene 1 (BRG1) ATPase Activity for the Treatment of SWItch/Sucrose Non-Fermentable (SWI/SNF) Dependent CancersRishi G Vaswani, David S Huang, Neville Anthony, et al.
Cancer Discovery|April 17, 2018
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Justin F Gainor, Rami Rahal, et al.
Pageof 3